Virtual Medicinal Product (VMP) - Nabumetone 500mg/5ml oral-suspension
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Nabumetone 500mg/5ml oral-suspension | Start Date 08-06-2016 | End Date |
Previous Name | Previous Name Nabumetone 500mg/5ml oral suspension | Start Date 16-05-2016 |
End Date
|
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Invalid
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- BNF Codes
-
- BNF code 10010100
Code | Start Date | End Date |
---|---|---|
329912003 | 19-05-2016 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Nabumetone | Based on Ingredient Substance | 100 mg | 1 ml |
Name
Nabumetone
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
100.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMNabumetone
-
VMP(Current) Nabumetone 500mg/5ml oral-suspension
-
AMPNo AMP's
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
1 ml |